Old Web
English
Sign In
Acemap
>
Paper
>
COT-17 EFFECT OF BEVACIZUMAB AGAINST CYSTIC COMPONENT OF PRIMARY/METASTATIC BRAIN TUMORS
COT-17 EFFECT OF BEVACIZUMAB AGAINST CYSTIC COMPONENT OF PRIMARY/METASTATIC BRAIN TUMORS
2019
Fumiyuki Yamasaki
Motoki Takano
Ushio Yonezawa
Akira Taguchi
Shumpei Onishi
Kaoru Kurisu
Kazuhiko Sugiyama
Keywords:
Bevacizumab
Oncology
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]